Sign in

or Register now

OsteoporosisConnection.com

See all of our health sites at www.HealthCentral.com
Sunday, October, 25, 2009

Latest Treatment For Osteoporosis

FDA approves once-a-year osteoporosis med

October 03, 2008
The Food and Drug Administration has approved Reclast for sale on the U.S. market. Reclast is the first once-a-year treatment for osteoporosis. It is designed to be given in an annual 15-minute intravenous treatment to women who have postmenopausal osteoporosis. Read more »

Expert & Community Posts

9487_4775
Osteoporosis Doctor Wins Award from Ladies' Home Journal
By Lila de Tantillo , Health Expert

The Ladies' Home Journal just announced their 2007 Health Breakthrough Award recipients, and they... Read more »

9487_4775
zoledronic acid update
By Lila de Tantillo , Health Expert

Zoledronic acid has received a positive approval recommendation in Europe for use in the treatment... Read more »

9487_4775
Zoledronic Acid Approved in Canada for Postmenopausal Osteoporosis
By Lila de Tantillo , Health Expert

Zoledronic acid, a once-yearly infusion, has been approved by Health Canada for treatment of... Read more »

9487_4775
New Osteoporosis Drug (SERM) Closer to Market
By Lila de Tantillo , Health Expert

Wyeth is moving forward with its new drug to combat osteoporosis in post-menopausal women. The FDA... Read more »

73_5766
Evista (Raloxifene), Breast Cancer and Osteoporosis
By Neil Gonter, MD , Health Expert

For the past few years, most physicians have routinely treated osteoporosis in the same manner. ... Read more »

Health Guide

Medical and Dental Concerns About Fosmax, Bisphosphonates
...include Fosamax (Alendronate), Actonel, Boniva, Didronel and Skelid and are commonly prescribed as treatments for osteoporosis and osteopenia in post-menopausal women.    Intravenous... Read more »
Osteoporosis: Introduction
Ibandronate (Boniva) approved as first once-a-month pill for both treatment and prevention of osteoporosis.Ibandronate (Boniva) injection approved as the first intravenous... Read more »
Parkinson's Disease: Highlights
Drug ApprovalIn 2006, the FDA approved rasagiline (Azilect) for treatment of Parkinsons disease (PD). Rasagilineis used either alone or in combination with levodopa. It is taken once a day... Read more »
Osteoporosis: Medications
...and treated according to recommended guidelines. In one of the studies, only 24% of women were given treatments for osteoporosis after a fracture. In both studies, the older a woman was the less... Read more »
Osteoporosis: Fractures
FracturesBone density loss from osteoporosis is a major cause of disability and death in the elderly, mostly due to subsequent fractures. The lifetime risk of spinal fracture in women is about one in... Read more »

Images

17287_1349_5
Osteoporosis and Loss of Height

View an image showing the effects of osteoporosis on our bodies.... Read more »

Related News

Study: Monitoring Bone Density Unnecessary, Potentially Misleading
July 10, 2009

(Ivanhoe Newswire) -- Regular bone mineral density monitoring in postmenopausal women may be unnecessary and potentially misleading. Researchers... Read summary »

Drug Heals Broken Bones
June 08, 2009

(Ivanhoe Newswire) -- A drug approved for the treatment of osteoporosis is healing broken bones with stem cells. Since 2002, teriparatide (Forteo)... Read summary »

Osteoporosis Drugs Linked to Heart Problems
November 26, 2008

(Ivanhoe Newswire) -- The millions of Americans who take drugs commonly prescribed to treat osteoporosis could be at risk for irregular heartbeats,... Read summary »

Guts Grow Bones
December 29, 2008

(Ivanhoe Newswire) -- A surprising new discovery in how bones grow may lead to a novel treatment of osteoporosis. Bone growth is controlled in the... Read summary »

Once-a-Year Drug Lowers Fracture Risk
May 09, 2007

(Ivanhoe Newswire) -- Postmenopausal women with osteoporosis may only need one dose of medication per year to reduce the risk of fractures. A new... Read summary »